NVO

Novo Nordisk
NVO

Delisted

NVO was delisted on the 15th of May, 2026.

Back to rankings
Upgrade to unlock
Buy
Hold
Sell

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
Avg. target
$41
High target

1 analyst rating

positive
1  neutral
100%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Goldman Sachs
Goldman Sachs
James Quigley
0% 1-yr NVO win rate
2 Mar ‘26 2 months ago
JP Morgan
JP Morgan
Richard Vosser
24 Feb ‘26 2 months ago